aspirin has been researched along with fibrinopeptide a in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (33.33) | 18.7374 |
1990's | 11 (52.38) | 18.2507 |
2000's | 3 (14.29) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Góra, P; Krzanowski, M; Radwan, J; Szczeklik, A | 1 |
Garabedian, HD; Gold, HK | 1 |
Addonizio, VP; Bell, P; Campbell, F; Ellison, N; Fisher, CA; Kappa, JR; Stenach, N; Todd, B | 1 |
Abbate, R; Poggesi, L; Prisco, D; Rostagno, C | 1 |
Krzanowski, M; Schmitz-Schumann, M; Szczeklik, A; Virchow, C | 1 |
Bucchi, F; Cerletti, C; Davies, JA; de Gaetano, G; Donati, MB; Hampton, KK; Loizou, LA; Prentice, CR | 1 |
Addonizio, VP; Berkowitz, HD; Cottrell, ED; Ellison, N; Fisher, CA; Kappa, JR; Sobel, M | 1 |
Belloni, M; Casonato, A; Fabris, F; Girolami, A; Ongaro, G; Quaino, V; Randi, ML | 1 |
Kakkar, VV; Kyrle, PA; Lewis, GP; Scully, MF; Westwick, J | 1 |
Douglas, JT; Forbes, CD; Lowe, GD; Prentice, CR; Stewart, ME | 1 |
Foadi, M; Ireland, H; Lane, DA; Wolff, S | 1 |
Edwards, RL; Rickles, FR | 1 |
Blombäck, M; Ek, I; Thunell, S | 1 |
Biagini, D; Cecioni, I; Colella, A; Costoli, A; Migliorini, A; Modesti, PA; Neri Serneri, GG | 1 |
Beer, JH; Rihs, F; Sturzenegger, M | 1 |
Bakken, IJ; Barstad, RM; Kierulf, P; Orvim, U; Roald, HE; Sakariassen, KS | 1 |
Haeberli, A; Marchetti, O; Mombelli, G; Straub, PW | 1 |
Gajewski, P; Góra, P; Jankowski, M; Musiał, J; Swadźba, J; Szczeklik, A; Undas, A | 1 |
Haug, KB; Joø, GB; Kierulf, P; Osnes, LT; Ovstebø, R; Westvik, AB | 1 |
Butenas, S; Cawthern, KM; DiLorenzo, ME; Lock, JB; Mann, KG; van't Veer, C | 1 |
Barzegar, S; Bauer, K; Costigan, T; Furie, KL; Kistler, JP; Mohr, JP; Rosenberg, R; Rosner, B; Sciacca, R; Thompson, JL; Thornell, B | 1 |
3 trial(s) available for aspirin and fibrinopeptide a
Article | Year |
---|---|
Antiplatelet drugs and generation of thrombin in clotting blood.
Topics: Adult; Aspirin; Blood Coagulation; Female; Fibrinopeptide A; Humans; In Vitro Techniques; Indomethacin; Kinetics; Male; Mathematics; Methacrylates; Middle Aged; Models, Biological; Platelet Aggregation Inhibitors; Skin; Thrombin; Thromboxane-A Synthase; Ticlopidine | 1992 |
Coagulation, fibrinolytic and platelet function in patients on long-term therapy with aspirin 300 mg or 1,200 mg daily compared with placebo.
Topics: Aged; Aged, 80 and over; Aspirin; Bleeding Time; Blood Coagulation; Dose-Response Relationship, Drug; Female; Fibrinolysis; Fibrinopeptide A; Humans; Male; Middle Aged; Placebos; Plasminogen Activators; Platelet Aggregation; Platelet Aggregation Inhibitors; Salicylates; Thromboembolism; Thromboxane B2; Time Factors | 1990 |
Inhibition of thrombin generation by simvastatin and lack of additive effects of aspirin in patients with marked hypercholesterolemia.
Topics: Adult; Aspirin; Biomarkers; Cholesterol; Drug Synergism; Drug Therapy, Combination; Fibrinopeptide A; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Peptide Fragments; Platelet Aggregation Inhibitors; Prognosis; Prothrombin; Safety; Simvastatin; Thrombin; Triglycerides | 1999 |
18 other study(ies) available for aspirin and fibrinopeptide a
Article | Year |
---|---|
Coronary thrombolysis, conjunctive heparin infusion, and the effect on systemic thrombin activity.
Topics: Aspirin; Coronary Thrombosis; Fibrinolytic Agents; Fibrinopeptide A; Heparin; Humans; Myocardial Infarction; Thrombin; Tissue Plasminogen Activator | 1992 |
Intraoperative management of patients with heparin-induced thrombocytopenia.
Topics: Adult; Aged; Aspirin; beta-Thromboglobulin; Bleeding Time; Epoprostenol; Fibrinopeptide A; Heparin; Humans; Iloprost; Intraoperative Period; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Factor 4; Thrombocytopenia; Thromboxane B2 | 1990 |
Pulmonary hypertension associated with long-standing thrombocytosis.
Topics: Adult; Aspirin; beta-Thromboglobulin; Fibrinopeptide A; Heparin; Humans; Hypertension, Pulmonary; Male; Platelet Activation; Splenectomy; Thalassemia; Thrombocytosis; Thromboxane A2; Time Factors | 1991 |
Delayed generation of thrombin in clotting blood of atopic patients with hayfever and asthma.
Topics: Aspirin; Asthma; Bleeding Time; Fibrinopeptide A; Hemostasis; Humans; Rhinitis, Allergic, Seasonal; Thrombin | 1991 |
Carotid endarterectomy in patients with heparin-induced platelet activation: comparative efficacy of aspirin and iloprost (ZK36374).
Topics: Aged; Aspirin; beta-Thromboglobulin; Cardiovascular Agents; Carotid Arteries; Drug Evaluation; Endarterectomy; Epoprostenol; Fibrinopeptide A; Heparin; Humans; Iloprost; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Platelet Factor 4; Preoperative Care; Thrombosis | 1987 |
Effect of heparin and aspirin on platelet and clotting activation during leukapheresis.
Topics: Adult; Aspirin; beta-Thromboglobulin; Blood Coagulation; Blood Platelets; Female; Fibrinopeptide A; Heparin; Humans; Leukapheresis; Male; Middle Aged; Serotonin | 1985 |
Investigation of the interaction of blood platelets with the coagulation system at the site of plug formation in vivo in man--effect of low-dose aspirin.
Topics: Adult; Aspirin; beta-Thromboglobulin; Bleeding Time; Blood Coagulation; Blood Platelets; Fibrinopeptide A; Hemostasis; Humans; Male; Platelet Aggregation; Thrombin; Thromboxane B2 | 1987 |
Prognostic value of beta-thromboglobulin in patients with transient cerebral ischaemia.
Topics: Adult; Age Factors; Aged; Aspirin; Beta-Globulins; beta-Thromboglobulin; Blood Platelets; Cerebrovascular Disorders; Dipyridamole; Female; Fibrinopeptide A; Humans; Ischemic Attack, Transient; Male; Middle Aged; Prognosis; Risk; Time Factors | 1983 |
In vivo platelet release in myeloproliferative disorders.
Topics: Aged; Aspirin; beta-Thromboglobulin; Blood Platelets; Fibrinopeptide A; Fibrinopeptide B; Humans; Middle Aged; Myeloproliferative Disorders; Platelet Aggregation; Platelet Count; Polycythemia Vera; Primary Myelofibrosis | 1982 |
Activation of blood coagulation in cancer: Trousseau's syndrome revisited.
Topics: Antibodies; Aspirin; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Platelets; Cell Adhesion; Cell Communication; Cyclooxygenase Inhibitors; Disseminated Intravascular Coagulation; Epoprostenol; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Indomethacin; Monocytes; Neoplasm Transplantation; Neoplasms; Syndrome; Thrombocytopenia; Thrombocytosis; Thromboembolism; Thromboplastin | 1983 |
Enhanced in vivo platelet activation in diabetes mellitus.
Topics: Adult; Aged; Aging; Aspirin; Blood Platelets; Calcium Channel Blockers; Cardiovascular Diseases; Diabetes Complications; Diabetes Mellitus; Female; Fibrinopeptide A; Humans; Insulin; Male; Middle Aged; Platelet Count; Platelet Factor 4 | 1982 |
Increased number of thromboxane A2-prostaglandin H2 platelet receptors in active unstable angina and causative role of enhanced thrombin formation.
Topics: Aged; Angina Pectoris; Angina, Unstable; Aspirin; Blood Platelets; Dose-Response Relationship, Drug; Fibrinopeptide A; Heparin; Humans; Middle Aged; Physical Exertion; Platelet Activation; Prostaglandins H; Radioligand Assay; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Thrombin; Thromboxane A2 | 1995 |
Monitoring combined antithrombotic treatments in patients with prosthetic heart valves using transcranial Doppler and coagulation markers.
Topics: Administration, Oral; Adult; Antithrombin III; Aspirin; beta-Thromboglobulin; Biomarkers; Coumarins; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Fibrinopeptide A; Heart Valve Prosthesis; Heparin; Humans; Injections, Intravenous; Male; Middle Aged; Peptide Hydrolases; Postoperative Complications; Thromboembolism; Ultrasonography, Doppler, Transcranial | 1995 |
Modulation of thrombotic responses in moderately stenosed arteries by cigarette smoking and aspirin ingestion.
Topics: Adult; Arteries; Aspirin; beta-Thromboglobulin; Blood Platelets; Cell Adhesion; Collagen; Constriction, Pathologic; Female; Fibrin; Fibrinopeptide A; Hematocrit; Humans; Male; Middle Aged; Platelet Count; Smoking; Thrombosis | 1994 |
Effect of intravenous heparin infusion on thrombin-antithrombin complex and fibrinopeptide A in unstable angina.
Topics: Aged; Angina, Unstable; Anticoagulants; Antithrombin III; Aspirin; Biomarkers; Female; Fibrinopeptide A; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Peptide Hydrolases; Prospective Studies | 1998 |
Aspirin potentiates LPS-induced fibrin formation (FPA) and TNF-alpha-synthesis in whole blood.
Topics: Aspirin; Blood Cells; Dinoprostone; Dose-Response Relationship, Drug; Fibrin; Fibrinopeptide A; Humans; Interleukin-10; Lipopolysaccharides; Monocytes; Peptide Fragments; Prothrombin; RNA, Messenger; Thromboplastin; Tumor Necrosis Factor-alpha | 2000 |
Antiplatelet agents in tissue factor-induced blood coagulation.
Topics: Abciximab; Adult; Alprostadil; Animals; Antibodies, Monoclonal; Antithrombin III; Aspirin; Blood Coagulation; Dipyridamole; Eptifibatide; Fibrinopeptide A; Humans; Immunoglobulin Fab Fragments; Mice; Osteonectin; Partial Thromboplastin Time; Peptide Hydrolases; Peptides; Plant Proteins; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Proteins; Prothrombin Time; Receptors, Thrombin; Thromboplastin | 2001 |
Thrombin generation in non-cardioembolic stroke subtypes: the Hemostatic System Activation Study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Biomarkers; Brain Infarction; Brain Ischemia; Cohort Studies; Comorbidity; Female; Fibrinopeptide A; Follow-Up Studies; Humans; International Normalized Ratio; Intracranial Thrombosis; Male; Middle Aged; Multicenter Studies as Topic; Peptide Fragments; Prothrombin; Randomized Controlled Trials as Topic; Recurrence; Stroke; Thrombin; Warfarin | 2004 |